Tango Therapeutics, Inc. (TNGX) News
Track canonical SquawkNews coverage tagged to TNGX, Tango Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
TNGX Files Prospectus For $400M Common Stock
Tango Therapeutics files prospectus for up to $400M common stock offering
EQUITY | Aug 11, 2026, 09:14 PM UTC
L
TNGX PT raised from $36 to $40, maintains Outperform @ Mizuho
TNGX PT raised from $36 to $40, maintains Outperform @ Mizuho
EQUITY | Jul 17, 2026, 11:25 AM UTC
L
TNGX Initiated Overweight W/$46.00 PT at JPMorgan
TNGX Initiated Overweight W/$46.00 PT at JPMorgan
EQUITY | Jul 15, 2026, 11:47 AM UTC
L
TNGX new Overweight W/ $46 PT @ JPMC
TNGX new Overweight W/ $46 PT @ JPMC
EQUITY | Jul 15, 2026, 11:22 AM UTC